Clinical outcomes in specialty pharmacy are more important than ever, yet many leaders still lack clear, comparable benchmarks to guide how they design, measure, and improve their programs. Leveraging data from the largest health‑system…
Specialty pharmacy outcomes, elevated at scale. Download the Full 2025 Specialty Pharmacy Outcomes Report The 5th Annual Shields Specialty Pharmacy Outcomes Report is here. Featuring results from more than 2…
See how your health system can retain specialty volume, strengthen financial performance, and improve patient outcomes with the right strategy and support. Health systems without fully integrated specialty pharmacy models…
The partnership, and investment from Shields, aims to enhance workflows for high-touch medications with innovative pharmacy operations technology, improving patient experience and reducing administrative burden STOUGHTON, Mass. (Jan. 13, 2026)…
Every year, more than 8,000 professionals and over 1,400 companies attend the leading specialty pharmacy conference in the nation, Asembia Summit 2025 marked its 21st anniversary — and we couldn’t be…
The partnership will support patients through personalized care, medications, and coordinationShields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, has partnered with Lakeland Regional Health, one of…
Accreditation positions health system specialty pharmacies to expand access to high-value medications and supports integrated caremodels shown to reduce healthcare costs.
This poster evaluates the impact of an ambulatory clinical pharmacist (ACP) program on third party pharmacy coverage determinationoutcomes for specialty oncology medications prescribed from these clinics.
This poster evaluate the challenges, time commitments, and resource allocation associated withachieving and maintaining SP accreditation among health-system specialty pharmacies.
This poster evaluates existing oral oncology medication waste events among patients filling at a health system specialty pharmacy (HSSP).